Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16241 | 28489136 | Rev Assoc Med Bras (1992) | Hyperferritinemia in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A16264 | 28479504 | Clin Gastroenterol Hepatol | Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis. | 2017 | Details |
| A16265 | 28479502 | Clin Gastroenterol Hepatol | Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis. | 2017 | Details |
| A16266 | 28479500 | Clin Gastroenterol Hepatol | Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16270 | 28475023 | Acta Radiol | Acoustic radiation force impulse imaging for detection of liver fibrosis in overweight and obese children. | 2017 | Details |
| A16273 | 28473066 | J Am Coll Radiol | ACR Appropriateness Criteria® Chronic Liver Disease. | 2017 | Details |
| A16277 | 28472477 | J Clin Endocrinol Metab | Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16278 | 28472039 | PLoS One | Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients. | 2017 | Details |
| A16286 | 28471474 | J Cell Physiol | Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells. | 2017 | Details |
| A16288 | 28470881 | Aliment Pharmacol Ther | Concentration-dependent response to pioglitazone in nonalcoholic steatohepatitis. | 2017 | Details |
| A16290 | 28470676 | Hepatology | Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study. | 2017 | Details |
| A16295 | 28469366 | Ann Gastroenterol | Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers. | 2017 | Details |
| A16298 | 28469217 | Am J Gastroenterol | Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock? | 2017 | Details |
| A16299 | 28469090 | JCI Insight | Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis. | 2017 | Details |
| A16300 | 28468951 | Clin Sci (Lond) | Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease. | 2017 | Details |
| A16303 | 28468017 | Dig Dis | Lessons from Epidemiology: The Burden of Liver Disease. | 2017 | Details |
| A16304 | 28468015 | Dig Dis | The Role of a Dedicated Non-Alcoholic Fatty Liver Disease Clinic in 2016. | 2017 | Details |
| A16306 | 28467925 | Cell Metab | Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16307 | 28467377 | Children (Basel) | Natural History of NAFLD Diagnosed in Childhood: A Single-Center Study. | 2017 | Details |
| A16314 | 28464257 | Aliment Pharmacol Ther | Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A16317 | 28462384 | Cell Mol Gastroenterol Hepatol | TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice. | 2017 | Details |
| A16320 | 28461687 | Int J Obes (Lond) | Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease. | 2017 | Details |
| A16322 | 28460180 | Can J Physiol Pharmacol | Role of folate in nonalcoholic fatty liver disease. | 2017 | Details |
| A16330 | 28456640 | Arch Biochem Biophys | Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease. | 2017 | Details |
| A16332 | 28454924 | Toxicol Appl Pharmacol | Dual effect of silymarin on experimental non-alcoholic steatohepatitis induced by irinotecan. | 2017 | Details |
| A16334 | 28452727 | Georgian Med News | [THE INFLUENCE OF LIFESTYLE ON BIOMARKERS OF FIBROSIS IN PATIENTS WITH STABLE CORONARY HEART DISEASE ON THE BACKGROUND OF NON-ALCOHOLIC FATTY LIVER DISEASE]. | 2017 | Details |
| A16336 | 28452101 | Diabetes Obes Metab | Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial. | 2017 | Details |
| A16344 | 28446050 | Scand J Gastroenterol | Smoking is associated with severity of liver fibrosis but not with histological severity in nonalcoholic fatty liver disease. Results from a cross-sectional study. | 2017 | Details |
| A16352 | 28442507 | J Endocrinol | Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice. | 2017 | Details |
| A16353 | 28442273 | Mol Aspects Med | The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2017 | Details |
| A16354 | 28442120 | Gastroenterology | American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. | 2017 | Details |
| A16371 | 28431668 | Diabetes Metab | GLP-1 receptor agonists in NAFLD. | 2017 | Details |
| A16380 | 28426902 | Liver Transpl | Hepatic steatosis after pediatric liver transplant. | 2017 | Details |
| A16386 | 28425401 | Ann Hepatol | MRE in NAFLD: Promising but Further Validation is Required. | 2017 | Details |
| A16388 | 28424263 | J Biol Chem | The kielin/chordin-like protein (KCP) attenuates high-fat diet-induced obesity and metabolic syndrome in mice. | 2017 | Details |
| A16389 | 28422962 | PLoS One | Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice. | 2017 | Details |
| A16391 | 28422172 | Sci Rep | Transient elastography as a screening tool for liver fibrosis in a large hemodialysis population. | 2017 | Details |
| A16392 | 28421320 | Histochem Cell Biol | Hepatocyte-specific depletion of ubiquitin regulatory X domain containing protein 8 accelerates fibrosis in a mouse non-alcoholic steatohepatitis model. | 2017 | Details |
| A16393 | 28420164 | Int J Mol Sci | The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function. | 2017 | Details |
| A16394 | 28420094 | Nutrients | Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. | 2017 | Details |
| A16395 | 28419855 | Clin Gastroenterol Hepatol | A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis. | 2017 | Details |
| A16396 | 28419755 | J Viral Hepat | A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B. | 2017 | Details |
| A16398 | 28419124 | PLoS One | A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis. | 2017 | Details |
| A16400 | 28417561 | CPT Pharmacometrics Syst Pharmacol | Population Pharmacokinetics of Morphine in Patients With Nonalcoholic Steatohepatitis (NASH) and Healthy Adults. | 2017 | Details |
| A16404 | 28415736 | Oncotarget | The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease. | 2017 | Details |
| A16408 | 28413661 | Mol Clin Oncol | Non-alcoholic fatty liver disease fibrosis score predicts hematological toxicity of chemotherapy including irinotecan for colorectal cancer. | 2017 | Details |
| A16414 | 28406477 | Cell Death Dis | miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice. | 2017 | Details |
| A16415 | 28405325 | United European Gastroenterol J | Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population. | 2016 | Details |
| A16417 | 28404158 | Lancet Gastroenterol Hepatol | Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review. | 2017 | Details |
| A16419 | 28404136 | Lancet Gastroenterol Hepatol | Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV. | 2017 | Details |
| A16420 | 28404113 | Lancet Gastroenterol Hepatol | Pathogenesis and novel treatment options for non-alcoholic steatohepatitis. | 2016 | Details |
| A16421 | 28404098 | Lancet Gastroenterol Hepatol | Screening for liver fibrosis in the general population: a call for action. | 2016 | Details |
| A16424 | 28398960 | AIDS | Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection. | 2017 | Details |
| A16435 | 28391883 | J Clin Lipidol | Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases. | 2016 | Details |
| A16456 | 28376114 | PLoS One | High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal. | 2017 | Details |
| A16462 | 28373874 | Front Immunol | Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration. | 2017 | Details |
| A16463 | 28373762 | World J Gastroenterol | Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease. | 2017 | Details |
| A16466 | 28371239 | Liver Int | The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. | 2017 | Details |
| A16470 | 28369989 | J Clin Ultrasound | Severity of nonalcoholic fatty liver disease on sonography and risk of coronary heart disease. | 2017 | Details |
| A16471 | 28369100 | PLoS One | Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease. | 2017 | Details |
| A16476 | 28366357 | J Pediatr | Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children. | 2017 | Details |
| A16482 | 28362682 | J Clin Gastroenterol | Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A16484 | 28359548 | Gastroenterol Hepatol | Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population. | 2017 | Details |
| A16487 | 28359088 | Endocrinology | Sex Hormone-Binding Globulin Reduction in Metabolic Disorders May Play a Role in NAFLD Development. | 2017 | Details |
| A16497 | 28352941 | Diabetologia | EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral? | 2017 | Details |
| A16505 | 28349045 | Can J Gastroenterol Hepatol | Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators. | 2017 | Details |
| A16513 | 28346543 | PLoS One | Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. | 2017 | Details |
| A16515 | 28346237 | Curr Opin Gastroenterol | Current and future pharmacologic treatment of nonalcoholic steatohepatitis. | 2017 | Details |
| A16517 | 28345499 | Br J Nutr | Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial. | 2017 | Details |
| A16518 | 28344991 | Mol Ther Methods Clin Dev | Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes. | 2016 | Details |
| A16523 | 28338115 | J Gastrointestin Liver Dis | Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-analysis. | 2017 | Details |
| A16529 | 28334911 | Hum Mol Genet | MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat. | 2017 | Details |
| A16547 | 28323124 | J Hepatol | CD44 is a key player in non-alcoholic steatohepatitis. | 2017 | Details |
| A16548 | 28322865 | Life Sci | Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling. | 2017 | Details |
| A16556 | 28318912 | Diabetes Metab | Less liver fibrosis in metabolically healthy compared with metabolically unhealthy obese patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A16565 | 28303974 | Sci Rep | Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis. | 2017 | Details |
| A16570 | 28300161 | Sci Rep | FOXO transcription factors protect against the diet-induced fatty liver disease. | 2017 | Details |
| A16577 | 28298270 | Adv Nutr | Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16579 | 28297806 | Zhonghua Gan Zang Bing Za Zhi | [Research advances in the pathogenesis of non-alcoholic fatty liver disease-associated liver cancer]. | 2017 | Details |
| A16589 | 28296807 | Transplantation | Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis. | 2017 | Details |
| A16594 | 28293382 | World J Hepatol | Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review. | 2017 | Details |
| A16599 | 28290069 | Clin J Gastroenterol | Significance of genetic polymorphisms in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A16602 | 28288202 | PLoS One | Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population. | 2017 | Details |
| A16603 | 28288193 | PLoS One | Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure. | 2017 | Details |
| A16605 | 28286271 | Biochem Biophys Res Commun | p16 deficiency promotes nonalcoholic steatohepatitis via regulation of hepatic oxidative stress. | 2017 | Details |
| A16607 | 28286193 | Clin Gastroenterol Hepatol | In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis. | 2017 | Details |
| A16608 | 28285648 | Metabolism | Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice. | 2017 | Details |
| A16611 | 28284005 | Curr HIV/AIDS Rep | Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV. | 2017 | Details |
| A16614 | 28282876 | Int J Mol Sci | Hepatic Transcriptome Profiles of Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E. | 2017 | Details |
| A16616 | 28281517 | Ter Arkh | [Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency]. | 2017 | Details |
| A16620 | 28281237 | Obes Surg | Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients. | 2017 | Details |
| A16625 | 28277807 | Expert Rev Clin Pharmacol | Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD). | 2017 | Details |
| A16627 | 28276821 | Expert Rev Gastroenterol Hepatol | Current and future treatment options in non-alcoholic steatohepatitis (NASH). | 2017 | Details |
| A16628 | 28276774 | Expert Rev Clin Pharmacol | Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes. | 2017 | Details |
| A16631 | 28274829 | Dig Liver Dis | Vitamin D and histologic severity of nonalcoholic fatty liver disease: A systematic review and meta-analysis. | 2017 | Details |
| A16635 | 28273155 | PLoS One | Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma. | 2017 | Details |
| A16639 | 28270882 | J Clin Med Res | Insulin-Like Growth Factor-1 Deficiency and Cirrhosis Establishment. | 2017 | Details |
| A16641 | 28270609 | Proc Natl Acad Sci U S A | Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis. | 2017 | Details |
| A16643 | 28269075 | Annu Int Conf IEEE Eng Med Biol Soc | Early diagnosis of NAFLD-NASH transition using mid infrared spectroscopy. | 2016 | Details |
| A16645 | 28267621 | J Hepatol | Targeting hepatic macrophages to treat liver diseases. | 2017 | Details |